Electrical Stimulation of the Dentate Nucleus Area (EDEN) for Improvement of Upper Extremity Hemiparesis Due to Ischemic Stroke: A Safety and Feasibility Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- Enspire DBS Therapy, Inc.
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Adverse Events
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This clinical trial will evaluate if Deep Brain Stimulation (DBS) is safe for the treatment of stroke and will help understand if DBS improves motor recovery for patients who continue to have significant impairment.
Detailed Description
The proposed study is a safety and feasibility study intended to provide preliminary data to design a future pilot study. The objective of this study is to document the safety and patient outcomes of electrical stimulation of the dentate nucleus area for the management of chronic, moderate to severe upper extremity hemiparesis due to ischemic stroke.
Investigators
Eligibility Criteria
Inclusion Criteria
- •One-time stroke that occurred 1-3 years ago (i.e. index stroke 12-36 months)
- •Stroke due to a blocked blood vessel (i.e. unilateral MCA stroke)
- •Moderate to severe weakness in one arm (i.e. unilateral upper-extremity hemiparesis)
Exclusion Criteria
- •Seizures since time of stroke (i.e. seizures or seizure disorder)
- •Unable to have an MRI (i.e. contraindicated for MRI)
Outcomes
Primary Outcomes
Adverse Events
Time Frame: 18 Months
Incidence of study-related serious adverse events